/

Empresas

To

No verificado

Topas Therapeutics

Sobre qué escribimos

BiotecnologíaCienciaFarmacéuticaIndustriaMedicina - Varios

3 Comunicados de prensa

Ver todos los comunicados de prensa

24/04/2025

Eventos

Industria

Salud

Medicina - Varios

Ciencia

Farmacéutica

Biotecnología

Topas Therapeutics Announces Presentation of Phase 2a Data for TPM502 in Celiac Disease at Digestive Disease Week® 2025 in San Diego

Fuente

Topas Therapeutics

Editor

1.00

0

17/03/2025

Industria

Salud

Medicina - Varios

Ciencia

Farmacéutica

Biotecnología

Topas Therapeutics Publishes Foundational Data Demonstrating Tolerance Induction by its Proprietary Nanoparticle Platform in Frontiers in Immunology

Fuente

Topas Therapeutics

Editor

1.00

0

15/10/2024

Industria

Salud

Medicina - Varios

Ciencia

Farmacéutica

Biotecnología

Topas Therapeutics Announces Positive Topline Results from Phase 2a Trial Evaluating TPM502 in Patients with Celiac Disease

Fuente

Topas Therapeutics

Editor

1.00

0

Seguidores

0

Compatibilidad

0